Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/1996
09/11/1996EP0730469A1 Modified truncated complement system regulators
09/11/1996EP0730458A1 Use of aldosterone antagonists to inhibit myocardial fibrosis
09/11/1996EP0730456A1 Antiarrhythmic benzodiazepines
09/11/1996EP0730455A1 Antiarrhythmic benzodiazepines
09/11/1996EP0730454A1 Antiarrhythmic benzodiazepines
09/11/1996EP0730453A1 Methods of treating cardiac arrhythmia
09/11/1996EP0730451A1 Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
09/11/1996EP0730445A1 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
09/11/1996EP0730444A1 Sustained release formulations for 24 hour release of metoprolol
09/11/1996EP0559677B1 Hydroxamic acids for preventing reperfusion injury
09/11/1996EP0450066B1 Carbostyril derivatives
09/11/1996CN1130874A Method of treating liver disease and like indications with vasodilating agents
09/11/1996CN1130866A Anti-angiogenic compositions and method of use
09/11/1996CN1130631A Cyclodlkano-indole and-azaindole derivatives
09/11/1996CN1130626A Adhesion receptor antagonists
09/11/1996CN1130532A Modulation of cellular activity
09/11/1996CN1130527A Xinshouling capsule for treating heart diseases
09/10/1996US5554641 Nonpeptides as tachykinin antagonists
09/10/1996US5554634 N-(hydroxyethyl)butanediamide derivatives
09/10/1996US5554624 Imidazopyridine derivatives as angiotensin II antagonists
09/10/1996US5554620 Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof
09/10/1996US5554613 Quinuclidine derivatives, qualene synthase inhibitors, treatment of hypercholesterolemia, atherosclerosis and fungus infections
09/10/1996US5554610 Inhalational treatment of pulmonary hypertension and related conditions
09/10/1996US5554599 22-thio vitamin D derivatives
09/10/1996CA2170818A1 Method of treating cardiac inflammatory disease
09/06/1996WO1996027007A1 A novel growth factor and a genetic sequence encoding same
09/06/1996WO1996027006A2 Human vegf-specific antisense oligonucleotides
09/06/1996WO1996026935A1 2-benzyl-3-arylbenzothiophenes
09/06/1996WO1996026931A1 Optically active thiazolidinone derivatives
09/06/1996WO1996026742A1 Gene transfer-mediated angiogenesis therapy
09/06/1996WO1996026736A1 Vascular endothelial growth factor-b
09/06/1996WO1996026728A2 Use of moxonidine for the treatment of atherosclerosis
09/06/1996WO1996026721A1 Remedy for pulmonary heart
09/06/1996WO1996021655A3 Substituted oxazolidine calpain and/or cathepsin b inhibitors
09/06/1996WO1996020690A3 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds
09/06/1996WO1996016981A3 Peptide compounds for prevention and/or treatment of no-mediated diseases
09/06/1996CA2214134A1 2-benzyl-3-arylbenzothiophenes
09/06/1996CA2212294A1 Use of moxonidine for the treatment of atherosclerosis
09/06/1996CA2188575A1 Gene transfer-mediated angiogenesis therapy
09/04/1996EP0729955A1 2-Benzyl-3-Arylbenzothiophenes useful for the treatment of post-menopausal syndrome
09/04/1996EP0729954A1 Substituted thiophene sulfonyl ureas and thioureas, process for their preparation, their use as medicaments
09/04/1996EP0729951A1 Naphthyl compounds, intermediates, compositions, and methods
09/04/1996EP0729753A1 Agents for treatment or prevention of hypertension and related symptons and disorders; their preparation and use
09/04/1996EP0729472A1 Piperidinylcamphorsulfonyl oxytocin antagonists
09/04/1996EP0729468A1 Non-peptide tachykinin receptor antagonists
09/04/1996EP0729459A1 Phenyl-alkyl imidazoles as h3-receptor antagonists
09/04/1996EP0729457A1 Diaminocyclobutene-3,4-diones as smooth muscle relaxants
09/04/1996EP0729359A1 A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor
09/04/1996EP0729352A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites
09/04/1996CN1130354A Compositions containing amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of decongestant an expectorant, an antihistamine and an antitussive
09/04/1996CN1130188A Salt of phosphonocarboxyl sulfonate zoomaricoene synthetic inhibitor and method
09/04/1996CN1130178A Alkyl-5-melhy/sulfonylbenzoy/guanidine derivatives
09/03/1996US5552536 DNA encoding precursor of interleukin-1 beta converting enzyme - related cysteine proteinase III (ice rel-III)
09/03/1996US5552520 Such as somatostatin analogs or bombesin analogs
09/03/1996US5552433 Method for lowering serum cholesterol
09/03/1996US5552429 Administering fluoxetine and pindolol to increase availability of serotonin, dopamine and norepinephrine
09/03/1996US5552424 Isoxazolines as antiinflammatory agents
09/03/1996US5552418 Trisubstituted Naphthylalkylamides
09/03/1996US5552412 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
09/03/1996US5552403 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
09/03/1996US5552401 2-benzyl-3-arylbenzothiophenes
09/03/1996US5552398 Treatment of irritable bowel diarrhea
09/03/1996US5552396 Bis-indolemaleimide macrocyclic derivatives,
09/03/1996US5552395 Bone disorders
09/03/1996CA2008972C Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
09/03/1996CA2007785C 1-[3-(2-hydroxy-3-alkylaminopropoxy)-2-thienyl] -3-phenyl-1-propanones and a process for the preparation thereof
08/1996
08/29/1996WO1996026205A1 Inhibitors of microsomal triglyceride transfer protein and method
08/29/1996WO1996026195A1 Benzothiazine dioxides as endothelin antagonists
08/29/1996WO1996026183A1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
08/29/1996WO1996025936A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/29/1996CA2213135A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/29/1996CA2211027A1 Benzothiazine dioxides as endothelin antagonists
08/29/1996CA2170337A1 Naphthyl compounds, intermediates, compositions, and methods
08/28/1996EP0728759A1 Heterocyclic compounds
08/28/1996EP0728758A1 Dioxopyrrolo-pyrrole derivatives
08/28/1996EP0728751A2 Process for the manufacture of diltiazem
08/28/1996EP0728746A1 Azepinone compounds useful in the inhibition of ACE and NEP
08/28/1996EP0728741A1 Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use in the production of pharmaceutical preparations and medicaments containing them
08/28/1996EP0728739A1 Biaromatic amide derivatives, pharmaceutical and cosmetic compositions containing them and their utilisations
08/28/1996EP0728210A1 Thrombin mutants
08/28/1996EP0728209A1 Endothelin-converting enzyme
08/28/1996EP0728147A1 Receptor specific atrial natriuretic peptides
08/28/1996EP0728145A1 Endothelin receptor antagonists
08/28/1996EP0728144A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
08/28/1996EP0728143A1 Oncoprotein protein kinase
08/28/1996EP0728128A1 Substituted phenyl compounds
08/28/1996EP0728009A1 Use of an agent which modulates tyrosine phosphorylation for modulating the permeability of a psychological barrier
08/28/1996EP0727997A1 Pharmaceutical emulsion
08/28/1996EP0727995A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
08/28/1996CN1129943A Vasoconstrictive substituted dihydropyranopyridines
08/28/1996CN1129935A Vasoconstrictive substituted aryloxyalkyl diamines
08/28/1996CN1129933A 5-arylindole derivatives
08/28/1996CN1129907A Inhibition of smooth muscle cell migration by (R)-amlodipine
08/28/1996CN1129906A Use of N-alkylated 1,4-dihydropyridine dicarboxylic acid esters as medicaments
08/28/1996CN1129702A Imidazopyridines
08/28/1996CN1129701A New diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
08/28/1996CN1129697A New 5-(aryloxymethyl) oxazolines, a process for the preparation thereof and pharmaceutical compositions containing them
08/28/1996CN1129566A Inhalant for preventing and remitting acute attack of cardio-cerebral diseases and preparation thereof
08/28/1996CN1032648C Process for preparation of platelet activating factor antagonist
08/27/1996US5550259 Dicitrate cyclic diester can be used to prevent or reduce the effects of calcification-related disease
1 ... 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 ... 1595